Health-related quality of life overlooked in drug studies extending progression free survival of cancer patients
McMaster UniversityGiven the increased use of progression-free survival as the primary outcome in new oncology drug trials, and uncertainty of overall survival, it remains possible that patients are receiving toxic and/or expensive treatments without experiencing important benefit.